Myomo (MYO) Liabilities and Shareholders Equity (2016 - 2025)

Myomo (MYO) posted Liabilities and Shareholders Equity of $38.6 million for Q4 2025, up 13.38% on a QoQ basis from $34.1 million in Q3 2025, and down 8.54% year-over-year from $42.2 million in Q4 2024.

Myomo (MYO) Liabilities and Shareholders Equity (2016 - 2025) Analysis & Trends

Myomo's Liabilities and Shareholders Equity history runs 10 years deep, the most recent figure standing at $38.6 million for Q4 2025.

  • Quarterly Liabilities and Shareholders Equity fell 8.54% year-over-year to $38.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $152.3 million (up 66.82% YoY) and the FY2025 annual result came in at $38.6 million, down 8.54% from the prior year.
  • Liabilities and Shareholders Equity was $38.6 million for Q4 2025 at Myomo, up from $34.1 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $42.2 million in Q4 2024 and bottomed at $10.2 million in Q4 2022.
  • A 5-year average of $21.7 million and a median of $17.3 million in 2021 frame the typical range for Liabilities and Shareholders Equity.
  • Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity sank 49.43% — and 2024, when it surged 189.71%.
  • Myomo's Liabilities and Shareholders Equity stood at $20.1 million in 2021, then sank by 49.43% to $10.2 million in 2022, then soared by 43.49% to $14.6 million in 2023, then jumped by 189.71% to $42.2 million in 2024, then dropped by 8.54% to $38.6 million in 2025.
  • Business Quant data shows MYO's Liabilities and Shareholders Equity at $38.6 million in Q4 2025, $34.1 million in Q3 2025, and $38.7 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 110.43 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 46.29 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 13.32 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 6.63 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 31.92 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 37.13 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 10.46 Bn
10 Myomo 39.24 Mn 20.27 Mn - 38.64 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 38.64 Mn
Sep 30, 2025 34.08 Mn
Jun 30, 2025 38.67 Mn
Mar 31, 2025 40.87 Mn
Dec 31, 2024 42.24 Mn
Sep 30, 2024 16.31 Mn
Jun 30, 2024 16.19 Mn
Mar 31, 2024 16.52 Mn
Dec 31, 2023 14.58 Mn
Sep 30, 2023 17.05 Mn
Jun 30, 2023 13.30 Mn
Mar 31, 2023 13.74 Mn
Dec 31, 2022 10.16 Mn
Sep 30, 2022 12.16 Mn
Jun 30, 2022 14.56 Mn
Mar 31, 2022 17.98 Mn
Dec 31, 2021 20.10 Mn
Sep 30, 2021 17.46 Mn
Jun 30, 2021 17.71 Mn
Mar 31, 2021 20.92 Mn